• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

依那西普治疗系统性红斑狼疮伴发难治性噬血细胞综合征。

Etanercept for the treatment of intractable hemophagocytic syndrome with systemic lupus erythematosus.

机构信息

Department of Microbiology and Immunology, Teikyo University School of Medicine, 2-11-1 Kaga, Itabashi-ku, Tokyo 173-8605, Japan.

出版信息

Mod Rheumatol. 2012 Apr;22(2):308-11. doi: 10.1007/s10165-011-0500-1. Epub 2011 Jul 20.

DOI:10.1007/s10165-011-0500-1
PMID:21773824
Abstract

A 41-year-old woman presented with continuous fever, and her laboratory data suggested the recrudescence of systemic lupus erythematosus. She was treated with 60 mg/day prednisolone. With a dose reduction of prednisolone, high fever and pancytopenia were observed again. A bone marrow biopsy revealed hemophagocytosis. The effects of steroid pulse therapy, high-dose intravenous immunoglobulin, cyclosporine A, and methotrexate were insufficient. However, after four injections of etanercept (25 mg, twice a week) subcutaneously, her symptoms had completely resolved. In such cases, therapy with etanercept may be effective.

摘要

一位 41 岁女性因持续发热就诊,实验室数据提示系统性红斑狼疮复发。给予她泼尼松龙 60mg/天治疗。随着泼尼松龙剂量的减少,再次出现高热和全血细胞减少。骨髓活检显示噬血细胞现象。虽然给予了激素冲击治疗、大剂量静脉注射免疫球蛋白、环孢素 A 和甲氨蝶呤治疗,但效果不佳。然而,皮下注射依那西普(25mg,每周两次,共 4 次)后,她的症状完全缓解。在这种情况下,依那西普治疗可能有效。

相似文献

1
Etanercept for the treatment of intractable hemophagocytic syndrome with systemic lupus erythematosus.依那西普治疗系统性红斑狼疮伴发难治性噬血细胞综合征。
Mod Rheumatol. 2012 Apr;22(2):308-11. doi: 10.1007/s10165-011-0500-1. Epub 2011 Jul 20.
2
Successful use of etanercept in the treatment of acute lupus hemophagocytic syndrome.依那西普成功用于治疗急性狼疮噬血细胞综合征。
Mod Rheumatol. 2008;18(1):72-5. doi: 10.1007/s10165-007-0006-z. Epub 2007 Dec 27.
3
Oral low-dose tacrolimus therapy for refractory hemophagocytic syndrome associated with systemic lupus erythematosus.口服低剂量他克莫司治疗与系统性红斑狼疮相关的难治性噬血细胞综合征。
Mod Rheumatol. 2012 Apr;22(2):284-9. doi: 10.1007/s10165-011-0491-y. Epub 2011 Jul 1.
4
Unusual acute lupus hemophagocytic syndrome - a test of diagnostic criteria: a case report.罕见急性狼疮噬血细胞综合征——诊断标准的检验:一例病例报告
J Med Case Rep. 2017 Jul 7;11(1):185. doi: 10.1186/s13256-017-1339-7.
5
Intractable Hemophagocytic Syndrome Associated with Systemic Lupus Erythematosus Resistant to Corticosteroids and Intravenous Cyclophosphamide That Was Successfully Treated with Cyclosporine A.与系统性红斑狼疮相关的难治性噬血细胞综合征,对皮质类固醇和静脉注射环磷酰胺耐药,经环孢素A成功治疗。
Intern Med. 2018 Sep 15;57(18):2747-2752. doi: 10.2169/internalmedicine.0571-17. Epub 2018 May 18.
6
Etanercept for therapy-resistant macrophage activation syndrome.依那西普用于治疗抵抗性巨噬细胞活化综合征。
Pediatr Blood Cancer. 2008 Feb;50(2):419-21. doi: 10.1002/pbc.21019.
7
Success with infliximab in treating refractory hemophagocytic lymphohistiocytosis.英夫利昔单抗治疗难治性噬血细胞性淋巴组织细胞增生症取得成功。
Am J Hematol. 2006 Jan;81(1):59-61. doi: 10.1002/ajh.20462.
8
Hemophagocytic Syndrome Complicated with Dermatomyositis Controlled Successfully with Infliximab and Conventional Therapies.英夫利昔单抗联合传统疗法成功控制噬血细胞综合征合并皮肌炎
Intern Med. 2017;56(23):3237-3241. doi: 10.2169/internalmedicine.7966-16. Epub 2017 Dec 1.
9
Cyclosporin rapidly diminished a severe lupus-associated macrophage association syndrome refractory to pulsed methylprednisolone and intravenous immunoglobulin.环孢素迅速减轻了一种严重的狼疮相关巨噬细胞关联综合征,该综合征对脉冲式甲泼尼龙和静脉注射免疫球蛋白治疗无效。
Scand J Rheumatol. 2009 Nov-Dec;38(6):492-4. doi: 10.3109/03009740902971221.
10
[Refractory subacute cutaneous lupus erythematosus treated with rituximab].利妥昔单抗治疗难治性亚急性皮肤型红斑狼疮
Actas Dermosifiliogr. 2012 Jul-Aug;103(6):555-7. doi: 10.1016/j.ad.2011.10.013. Epub 2012 Apr 5.

引用本文的文献

1
Riding the storm: managing cytokine-related toxicities in CAR-T cell therapy.乘风破浪:CAR-T 细胞疗法中细胞因子相关毒性的管理。
Semin Immunopathol. 2024 Jul 16;46(3-4):5. doi: 10.1007/s00281-024-01013-w.
2
Targeting TNF-α for COVID-19: Recent Advanced and Controversies.针对 COVID-19 的 TNF-α 靶点:最新进展与争议。
Front Public Health. 2022 Feb 11;10:833967. doi: 10.3389/fpubh.2022.833967. eCollection 2022.
3
Risk Assessment of Etanercept in Mice Chronically Infected With .依那西普在慢性感染……的小鼠中的风险评估
Front Microbiol. 2018 Nov 21;9:2822. doi: 10.3389/fmicb.2018.02822. eCollection 2018.
4
Epstein-Barr Virus and Hemophagocytic Lymphohistiocytosis.爱泼斯坦-巴尔病毒与噬血细胞性淋巴组织细胞增生症
Front Immunol. 2018 Jan 8;8:1902. doi: 10.3389/fimmu.2017.01902. eCollection 2017.
5
Refractory hemophagocytic syndrome in systemic lupus erythematosus successfully treated with intermittent intravenous cyclophosphamide: three case reports and literature review.间歇性静脉注射环磷酰胺成功治疗系统性红斑狼疮难治性噬血细胞综合征:三例报告及文献综述
Clin Rheumatol. 2014 Feb;33(2):281-6. doi: 10.1007/s10067-013-2451-8. Epub 2013 Dec 18.
6
Sequential monitoring of serum IL-6, TNF-α, and IFN-γ levels in a CAEBV patient treated by plasma exchange and immunochemotherapy.采用血浆置换和免疫化疗治疗 CAEBV 患者时,对其血清 IL-6、TNF-α 和 IFN-γ 水平进行连续监测。
Int J Hematol. 2012 Nov;96(5):669-73. doi: 10.1007/s12185-012-1170-2. Epub 2012 Sep 16.